THE CLIENT
Fortune 100 Healthcare Company
SITUATION
Separate pharmacovigilance processes, systems, data, and support functions into two independent organizations while ensuring both entities could meet critical drug safety reporting obligations on Day 1.
HOW WE HELPED
Peritius led cross-functional coordination across medical, technology, and support teams to manage the separation. We worked with leadership to establish system ownership, develop knowledge transfer plans, and build new support capabilities while maintaining operational and regulatory continuity.
RESULT
Both organizations successfully met their Day 1 regulatory commitments. Transitional services were implemented, with the plan to exit those agreements within 24 months remaining on schedule.